Rapid method for detection of minimal bactericidal concentration of antibiotics

被引:27
作者
Baer, Werner [2 ]
Baede-Schumann, Ulrike [2 ]
Krebs, Andreas [1 ]
Cromme, Ludwig [1 ]
机构
[1] Brandenburg Tech Univ Cottbus, Cottbus, Germany
[2] Carl Thiem Klinikum Cottbus, Inst Med Mikrobiol & Krankenhaushyg, Cottbus, Germany
关键词
Minimal bactericidal concentration; Fluorescence; FLOW-CYTOMETRY; IN-VITRO; CLINICAL MICROBIOLOGY; NATIONAL COMMITTEE; FLUORESCENT-PROBES; ESCHERICHIA-COLI; CANCER-PATIENTS; SUSCEPTIBILITY; IDENTIFICATION; CEFEPIME;
D O I
10.1016/j.mimet.2009.01.010
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We developed a test for rapid determination of the minimal bactericidal concentration (MBC) of antibiotics. MBC is determined by calculating the relative proportion of live and dead bacteria by means of two fluorescence dyes: Syto 9 (which detects only live bacteria) and Propidium iodide (which labels live and dead bacteria). Testing was performed in micro-titer plates. Determination of bacterial viability was performed after exposure to antibiotics for 4 h. Reference strains and clinical isolates of Escherichia coli and Pseudomonas aeruginosa were tested. Fluorescence-based determination (MBC/F) and reference methods (MBC/L) were comparable (+/- 1 Dilution step), except for E. coli with piperacillin and cefotaxime, which differed up to two steps. Bactericidal activity against E. coli/P. aeruginosa was observed: Meropenem (100%/100%), gentamicin (100%/9.3%), ciprofloxacin (93.3%/86.7%), cefotaxime (E. coli only: 86.7%) ceftazidime (P. aeruginosa only: 80%), piperacillin (56.6%/76.7%). The calculation of MBC has been achieved by graphical extrapolation and mathematical approximation method. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:85 / 89
页数:5
相关论文
共 29 条
[1]   CHARACTERIZATION OF BACTERIA BY MULTIPARAMETER FLOW-CYTOMETRY [J].
ALLMAN, R ;
HANN, AC ;
MANCHEE, R ;
LLOYD, D .
JOURNAL OF APPLIED BACTERIOLOGY, 1992, 73 (05) :438-444
[2]   Applications of flow cytometry to clinical microbiology [J].
Alvarez-Barrientos, A ;
Arroyo, J ;
Cantón, R ;
Nombela, C ;
Sánchez-Pérez, M .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (02) :167-+
[3]   Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing [J].
Barenfanger, J ;
Drake, C ;
Kacich, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1415-1418
[4]   Pseudomonas aeruginosa infections in cancer patients:: have they gone away? [J].
Bodey, GP .
CURRENT OPINION IN INFECTIOUS DISEASES, 2001, 14 (04) :403-407
[5]   LIVE/DEAD® BacLight™:: application of a new rapid staining method for direct enumeration of viable and total bacteria in drinking water [J].
Boulos, L ;
Prévost, M ;
Barbeau, B ;
Coallier, J ;
Desjardins, R .
JOURNAL OF MICROBIOLOGICAL METHODS, 1999, 37 (01) :77-86
[6]  
BOYE E, 1983, J GEN MICROBIOL, V129, P973
[7]   Comparison and evaluation of antimicrobial susceptibility testing of enterococci performed in accordance with six national committee standardized disk diffusion procedures [J].
Cotter, G ;
Adley, CC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) :3753-3756
[9]   ANTIMICROBIAL SUSCEPTIBILITY TESTS AND THEIR ROLE IN THERAPEUTIC DRUG-MONITORING [J].
DEGIROLAMI, PC ;
ELIOPOULOS, G .
CLINICS IN LABORATORY MEDICINE, 1987, 7 (03) :499-512
[10]   CLINICAL IMPACT OF RAPID IN-VITRO SUSCEPTIBILITY TESTING AND BACTERIAL IDENTIFICATION [J].
DOERN, GV ;
VAUTOUR, R ;
GAUDET, M ;
LEVY, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (07) :1757-1762